T0	Participants 47 108	patients with acute ischaemic stroke and atrial fibrillation:
T1	Participants 212 272	Patients with acute ischaemic stroke and atrial fibrillation
T2	Participants 589 703	low-molecular-weight heparin (LMWH, dalteparin 100 IU/kg subcutaneously twice a day) or aspirin (160 mg every day)
T3	Participants 725 790	449 patients with acute ischaemic stroke and atrial fibrillation.